Clinical Trials Directory

Trials / Completed

CompletedNCT02135965

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate.

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to define a ratio of Caffeine and albuterol that gives a synergistic increase in metabolic rate.

Detailed description

The study consists of 2 screening visits and 8 study visits. Screening visit 1: about 1 hour fasting from 9pm the prior night. Height and weight is measured, vital signs taken and questionnaires completed. Women will have a urine pregnancy test. Blood draw for chemistry panel and blood count. Screening visit 2: about 1 hour, Medical history, physical examination, and electrocardiogram (a heart tracing). Visit 1-8 about 4 hours each. 8 separate occasions, with about 7 days between each visit. ON each visit, blood pressure, pulse and temperature is recorded. A resting metabolic rate (RMR) is measured. After a baseline measurement of about 30 minutes of breathing is taken , a pill will be swallow and metabolism(measured by breathing with a clear plastic hood over the upper body to measure metabolic rate ( the oxygen inhaled and the carbon dioxide exhaled).

Conditions

Interventions

TypeNameDescription
DRUG2mg of Albuterol2mg of Albuterol on metabolic rate
DRUG4mg of Albuterol4mg of Albuterol on metabolic rate
DRUG100mg of Caffeine100mg of caffeine on metabolic rate
DRUG200mg of Caffeine200mg of Caffeine on metabolic rate
DRUGAlbuterol 2mg & Caffeine 100mgAlbuterol 2mg and 100mg of Caffeine
DRUGAlbuterol 2mg and Caffeine 200mgAlbuterol 2mg and Caffeine 200mg on metabolic rate
DRUGAlbuterol 4mg and Caffeine 100mgAlbuterol 4mg and Caffeine 100mg on metabolic rate
DRUGAlbuterol 4mg and Caffeine 200mgAlbuterol 4mg and Caffeine 200mg on metabolic rate

Timeline

Start date
2009-04-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2014-05-12
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02135965. Inclusion in this directory is not an endorsement.